We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Bracco Acquires Acist Medical Systems

By HospiMedica staff writers
Posted on 12 Jul 2001
Print article
An important supplier of advanced injection systems for contrast media, Acist Medical Systems Inc. (Minneapolis, MN, USA), has been acquired by the Bracco Group (Milan, Italy), which occupies a prominent position in the field of diagnostic imaging. Terms were not disclosed. Acist expects 2001 sales to reach about US$20 million.

Acist currently has more than 500 of its injection systems installed throughout the world. Its devices allow fully automatic and controlled administration of fluids injected during x-ray procedures, increasing safety and reliability while reducing cost and execution time. These devices allow a doctor to pre-program pressure, volume, and flow of the fluids used in cardiac catheterization procedures, including contrast media.

The acquisition expands Bracco's line of products in the field of diagnostic imaging. It also fits with Bracco's overall acquisition strategy, begun in the late 1990s, with the purchase of a controlling interest in the Esaote Group and the buyback of Merck's share in Bracco. The company had sales of $900 million in 2000. "Acist will strengthen our integrated imaging products and systems portfolio, which ranges from tools used purely for diagnosis to systems used for interventional procedures and post-operative follow-up,” said Diana Bracco, CEO of Bracco.




Related Links:
Bracco
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Fixed Volume Dispense Pump
LPL Series
New
Mobile Patient Lift
Golvo 9000

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.